Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.65 USD 2.07% Market Closed
Market Cap: 145.4B USD
Have any thoughts about
Pfizer Inc?
Write Note

Intrinsic Value

The intrinsic value of one PFE stock under the Base Case scenario is 24.05 USD. Compared to the current market price of 25.65 USD, Pfizer Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PFE Intrinsic Value
24.05 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Pfizer Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PFE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PFE?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Pfizer Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Pfizer Inc

Provide an overview of the primary business activities
of Pfizer Inc.

What unique competitive advantages
does Pfizer Inc hold over its rivals?

What risks and challenges
does Pfizer Inc face in the near future?

Has there been any significant insider trading activity
in Pfizer Inc recently?

Summarize the latest earnings call
of Pfizer Inc.

What significant events have occurred
in Pfizer Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pfizer Inc.

Provide P/S
for Pfizer Inc.

Provide P/E
for Pfizer Inc.

Provide P/OCF
for Pfizer Inc.

Provide P/FCFE
for Pfizer Inc.

Provide P/B
for Pfizer Inc.

Provide EV/S
for Pfizer Inc.

Provide EV/GP
for Pfizer Inc.

Provide EV/EBITDA
for Pfizer Inc.

Provide EV/EBIT
for Pfizer Inc.

Provide EV/OCF
for Pfizer Inc.

Provide EV/FCFF
for Pfizer Inc.

Provide EV/IC
for Pfizer Inc.

Show me price targets
for Pfizer Inc made by professional analysts.

What are the Revenue projections
for Pfizer Inc?

How accurate were the past Revenue estimates
for Pfizer Inc?

What are the Net Income projections
for Pfizer Inc?

How accurate were the past Net Income estimates
for Pfizer Inc?

What are the EPS projections
for Pfizer Inc?

How accurate were the past EPS estimates
for Pfizer Inc?

What are the EBIT projections
for Pfizer Inc?

How accurate were the past EBIT estimates
for Pfizer Inc?

Compare the revenue forecasts
for Pfizer Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pfizer Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pfizer Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pfizer Inc compared to its peers.

Compare the P/E ratios
of Pfizer Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Pfizer Inc with its peers.

Analyze the financial leverage
of Pfizer Inc compared to its main competitors.

Show all profitability ratios
for Pfizer Inc.

Provide ROE
for Pfizer Inc.

Provide ROA
for Pfizer Inc.

Provide ROIC
for Pfizer Inc.

Provide ROCE
for Pfizer Inc.

Provide Gross Margin
for Pfizer Inc.

Provide Operating Margin
for Pfizer Inc.

Provide Net Margin
for Pfizer Inc.

Provide FCF Margin
for Pfizer Inc.

Show all solvency ratios
for Pfizer Inc.

Provide D/E Ratio
for Pfizer Inc.

Provide D/A Ratio
for Pfizer Inc.

Provide Interest Coverage Ratio
for Pfizer Inc.

Provide Altman Z-Score Ratio
for Pfizer Inc.

Provide Quick Ratio
for Pfizer Inc.

Provide Current Ratio
for Pfizer Inc.

Provide Cash Ratio
for Pfizer Inc.

What is the historical Revenue growth
over the last 5 years for Pfizer Inc?

What is the historical Net Income growth
over the last 5 years for Pfizer Inc?

What is the current Free Cash Flow
of Pfizer Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pfizer Inc.

Business Breakdown

Pfizer Inc. is a global leader in the pharmaceutical industry, renowned for its commitment to innovative research and development that drives breakthroughs in healthcare. Founded in 1849, Pfizer has evolved into a powerhouse, particularly highlighted by its pivotal role in developing one of the first COVID-19 vaccines in collaboration with BioNTech. This achievement not only underscored the company's rapid response capabilities but also significantly boosted its revenue, showcasing its ability to pivot in times of global health crises. Investors are drawn to Pfizer not just for its historical legacy, but also for its diverse portfolio that includes treatments across various therapeutic areas...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pfizer Inc

Current Assets 37.8B
Cash & Short-Term Investments 7.1B
Receivables 15.1B
Other Current Assets 15.6B
Non-Current Assets 178.4B
Long-Term Investments 11.1B
PP&E 19B
Intangibles 129.7B
Other Non-Current Assets 18.6B
Current Liabilities 43.8B
Accounts Payable 5.1B
Accrued Liabilities 2.6B
Short-Term Debt 8.2B
Other Current Liabilities 27.9B
Non-Current Liabilities 84.7B
Long-Term Debt 57.5B
Other Non-Current Liabilities 27.2B
Efficiency

Earnings Waterfall
Pfizer Inc

Revenue
60.1B USD
Cost of Revenue
-17.5B USD
Gross Profit
42.6B USD
Operating Expenses
-29.4B USD
Operating Income
13.1B USD
Other Expenses
-8.9B USD
Net Income
4.3B USD

Free Cash Flow Analysis
Pfizer Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Pfizer reported a robust Q3 2024 with revenues of $17.7 billion, reflecting a 32% operational growth. They raised their full-year revenue guidance by $1.5 billion, now expecting $61 to $64 billion, and adjusted earnings per share to $2.75 to $2.95. Noteworthy contributions were from PAXLOVID and COMIRNATY, estimated at $5.5 billion and $5 billion, respectively. The non-COVID business grew 14% year-over-year, supporting a stable operational foundation. Pfizer is on track to deliver $4 billion in cost savings while maintaining a commitment to growing dividends, demonstrating strong cash flow management as they continue integrating recent acquisitions.

What is Earnings Call?
Fundamental Scores

PFE Profitability Score
Profitability Due Diligence

Pfizer Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
58/100
Profitability
Score

Pfizer Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

PFE Solvency Score
Solvency Due Diligence

Pfizer Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
37/100
Solvency
Score

Pfizer Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 32.95 USD with a low forecast of 25.25 USD and a high forecast of 47.25 USD.

Lowest
Price Target
25.25 USD
2% Downside
Average
Price Target
32.95 USD
28% Upside
Highest
Price Target
47.25 USD
84% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PFE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PFE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PFE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

PFE News

Other Videos

Profile

Pfizer Inc Logo
Pfizer Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

145.4B USD

Dividend Yield

6.55%

Description

Pfizer Inc. is a research-based global biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 79,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The firm offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The firm works across markets to develop wellness, prevention, treatments and cures. The company collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The firm's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.

Contact

NEW YORK
New York City
235 E 42nd St
+12125732323.0
www.pfizer.com

IPO

1944-01-17

Employees

79 000

Officers

Chairman of the Board & CEO
Dr. Albert Bourla D.V.M., Ph.D.
Chief Financial Officer & Executive VP
Mr. David M. Denton
Chief Scientific Officer and President of Research & Development
Dr. Mikael Dolsten M.D., Ph.D.
Executive VP & General Counsel
Mr. Douglas M. Lankler
Senior VP, Controller & Principal Accounting Officer
Ms. Jennifer B. Damico
Executive VP and Chief Digital & Technology Officer
Ms. Lidia L. Fonseca
Show More
Chief Investor Relations Officer
Ms. Francesca M. DeMartino
Executive VP and Chief Compliance, Quality & Risk Officer
Mr. Rady A. Johnson
Global Chief Marketing Officer
Mr. Andreas J. Panayiotou
Chief People Experience Officer & Executive VP
Ms. Payal Sahni Becher
Show Less

See Also

Discover More
What is the Intrinsic Value of one PFE stock?

The intrinsic value of one PFE stock under the Base Case scenario is 24.05 USD.

Is PFE stock undervalued or overvalued?

Compared to the current market price of 25.65 USD, Pfizer Inc is Overvalued by 6%.

Back to Top